Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
09 oct. 2023 07h50 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
06 oct. 2023 08h30 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
29 août 2023 07h35 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
10 août 2023 07h35 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
30 juin 2023 08h25 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
26 juin 2023 08h25 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
15 juin 2023 12h44 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., June 15, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
31 mai 2023 10h38 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
31 mai 2023 08h00 HE
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
11 mai 2023 07h45 HE
|
Reneo Pharmaceuticals, Inc.
Completed enrollment of the pivotal STRIDE study; topline results anticipated 4Q 2023Raised $68.3 million in gross proceeds from a concurrent public offering and private placement IRVINE, Calif.,...